Our team
Chief Executive Officer & Chief Medical Officer
Dr. Oral Alpan, MD
Renowned as a leader in the field of Immunology, Dr. Alpan has been a principal investigator in Phase I, II, III, and IV studies, and authored many publications in basic and clinical immunology and allergy.
oalpan@amerimmune.com
Chief Operating Officer
Ivan Santos
Ivan brings 30 years of experience in finance and operations, including Accenture and Northrop Grumman. Previously, he served as Chief Financial Officer of Kadix Systems and Kaseman, leading them through their exit strategy and eventual sale for over $200MM.
isantos@amerimmune.com
Scientist
Soren Sonder, PHD
He obtained his Ph.D. in 2006 from University of Copenhagen, Denmark and has also served as a postdoctoral researcher at the NIH and Johns Hopkins. Since joining Amerimmune Soren has focused on using flow cytometry to improve healthcare.
ssonder@amerimmune.com
Scientific Advisor
Gerald Marti, PHD
A 30 year veteran of both the NIH and FDA, Dr. Marti serves as a scientific advisor to Amerimmune's leadership on the path toward FDA approval. In 2012, Dr Marti was recipient of the ICCS Wallace H. Coulter Award in recognition of his many contributions to the field of clinical flow cytometry.
gmarti@amerimmune.com